Frontal cognitive-behavioural deficits in patients with anti-leucine-rich glioma-inactivated protein 1 antibody encephalitis

被引：0
|
作者：
Lee, Sydney [1 ]
Climans, Seth [2 ]
Day, Gregory [3 ]
Hebert, Julien [4 ]
Lapointe, Sarah [5 ]
Ramos, Ronald [6 ]
Steriade, Claude [7 ]
Wennberg, Richard [1 ]
Muccilli, Alexandra [8 ]
Tang-Wai, David [9 ]
机构：
[1] Univ Toronto, Toronto, ON, Canada
[2] London Hlth Sci Ctr, London, ON, Canada
[3] Mayo Clin, Rochester, MN USA
[4] Columbia Univ, Irving Medial Ctr, New York, NY USA
[5] CHUM, Montreal, PQ, Canada
[6] Juravinski Hosp & Canc Ctr, Hamilton, ON, Canada
[7] NYU, New York, NY USA
[8] St Michaels Hosp, Multiple Sclerosis Clin, Toronto, ON, Canada
[9] Univ Hlth Network, Toronto Western Hosp, Toronto, ON, Canada
来源：
NEUROLOGY | 2023年 / 100卷 / 17期
关键词：
D O I：
10.1212/WNL.0000000000202815
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
S22.004
引用
收藏
页数：4
相关论文
共 50 条
  • [1] A case of anti-leucine-rich glioma-inactivated 1 antibody-mediated limbic encephalitis
    Hye, Yena
    INTERNAL MEDICINE JOURNAL, 2019, 49 (07) : 932 - 933
  • [2] CXCL13 Is A Biomarker Of Anti-Leucine-Rich Glioma-Inactivated Protein 1 Encephalitis Patients
    Lin, You-ting
    Yang, Xue
    Lv, Jing-wei
    Liu, Xue-wu
    Wang, Sheng-jun
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2019, 15 : 2909 - 2915
  • [3] CXCL13 Is a Biomarker of Anti-Leucine-Rich Glioma-Inactivated Protein 1 Encephalitis Patients [Letter]
    Wei, Mingyu
    Duan, Zuowei
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2020, 16 : 181 - 182
  • [4] Leucine-rich glioma-inactivated protein 1 antibody encephalitis
    Mayasi, Yunis
    Takhtani, Deepak
    Garg, Neeta
    NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2014, 1 (04):
  • [5] Anti-leucine-rich glioma-inactivated 1 encephalitis with manic symptoms as the initial manifestation
    Tu, Tsung-Han
    Chan, Yee-Lam E.
    Bai, Ya-Mei
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2018, 52 (07): : 714 - 715
  • [6] Clinical features of anti-leucine-rich glioma-inactivated 1 encephalitis in northeast China
    Zhao, Qian
    Sun, Lichao
    Zhao, Danyang
    Chen, Yanyan
    Li, Mengmeng
    Lu, Yingxue
    Li, Guangjian
    Lin, Weihong
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2021, 203
  • [7] Residual Fatigue and Cognitive Deficits in Patients After Leucine-Rich Glioma-Inactivated 1 Antibody Encephalitis
    Binks, Sophie N. M.
    Veldsman, Michele
    Easton, Ava
    Leite, M. Isabel
    Okai, David
    Husain, Masud
    Irani, Sarosh R.
    JAMA NEUROLOGY, 2021, 78 (05) : 617 - 619
  • [8] Long-term seizure outcomes in patients with anti-Leucine-rich glioma-inactivated 1 encephalitis
    Lin, Nan
    Liu, Qing
    Chen, Jianhua
    Jin, Liri
    Huang, Yan
    Lu, Qiang
    Guan, Hongzhi
    EPILEPSY & BEHAVIOR, 2021, 122
  • [9] CXCL13 Is a Biomarker of Anti-Leucine-Rich Glioma-Inactivated Protein 1 Encephalitis Patients [Response to Letter]
    Wang, Sheng-jun
    Liu, Xue-wu
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2020, 16 : 339 - 340
  • [10] Cytokines/chemokines and immune checkpoint molecules in anti-leucine-rich glioma-inactivated 1 encephalitis
    Qiao, Shan
    Zhang, Shan-chao
    Li, Hai-yun
    Wang, Zhi-hao
    Jin, Yang
    Wang, Ai-hua
    Liu, Xue-wu
    NEUROLOGICAL SCIENCES, 2023, 44 (03) : 1017 - 1029
12345